Predicting COVID-19 Vaccine Acceptance Based on Mental Status, Trust in the Government, and Demographics among the Iranian
محورهای موضوعی :
Seyedeh Asma Hosseini
1
(Department of Psychology, Faculty of Education and Psychology, Alzahra University, Tehran, Iran )
کلید واژه: Covid-19, Vaccine, Acceptance, Anxiety, Depression, Mental status,
چکیده مقاله :
Adherence to vaccination and trust in the authorities' may vary between urban and rural areas due to social norms, the influence of culture, and the level of education. The study aimed to predict COVID-19 vaccine acceptance based on mental status, trust in the government, and demographics among the Tehran population in Iran. This study was conducted in Tehran from June 2021 and December 2021. Data were obtained by an electronic questionnaire through professional groups of social networks (Googleform). Information regarding demographic characteristics, marriage status, employment status, and monthly income in Iranian Rial, trust in government, anxiety, depression, psychological well-being, and psychological distress were collected. Moreover, participants were asked how strongly they accepted COVID-19 vaccine acceptance. Also, trust in Iranian and foreign vaccines- two questions evaluated the extent of trust in Iranian and foreign Covid-19 vaccine Of the 1209 participants surveyed, 792 (66.56%) reported that they would accept a COVID-19 vaccine if it is recommended for them. Then, 46.03% and 26.99% of participants reported that they preferred an Iranian vaccine and a foreign vaccine respectively. The strongest predictor of COVID-19 vaccine acceptance was trust in government, income, gender, well-being, and education. The strongest predictors of Iranian COVID-19 vaccine acceptance were "trust in government", income, well-being, and education. The strongest predictors of Iranian COVID-19 vaccine acceptance were "trust in government", gender and education. The results of the present study showed that a majority of participants (66.56%) from across Tehran would like to accept a COVID-19 vaccine; however, this level of acceptance may not be adequate based on some of the estimates COVID-19 herd immunity. The herd immunity point for COVID-19 is evaluated to be between 55% and 82% (32). Actual complete vaccination until February 2022 was 65% in Iran. The current estimation is very close to the real condition. However, acceptance was high, with 46.03% and 26.99% having to intend to have the Iranian and foreign vaccine respectively.
Adherence to vaccination and trust in the authorities' may vary between urban and rural areas due to social norms, the influence of culture, and the level of education. The study aimed to predict COVID-19 vaccine acceptance based on mental status, trust in the government, and demographics among the Tehran population in Iran. This study was conducted in Tehran from June 2021 and December 2021. Data were obtained by an electronic questionnaire through professional groups of social networks (Googleform). Information regarding demographic characteristics, marriage status, employment status, and monthly income in Iranian Rial, trust in government, anxiety, depression, psychological well-being, and psychological distress were collected. Moreover, participants were asked how strongly they accepted COVID-19 vaccine acceptance. Also, trust in Iranian and foreign vaccines- two questions evaluated the extent of trust in Iranian and foreign Covid-19 vaccine Of the 1209 participants surveyed, 792 (66.56%) reported that they would accept a COVID-19 vaccine if it is recommended for them. Then, 46.03% and 26.99% of participants reported that they preferred an Iranian vaccine and a foreign vaccine respectively. The strongest predictor of COVID-19 vaccine acceptance was trust in government, income, gender, well-being, and education. The strongest predictors of Iranian COVID-19 vaccine acceptance were "trust in government", income, well-being, and education. The strongest predictors of Iranian COVID-19 vaccine acceptance were "trust in government", gender and education. The results of the present study showed that a majority of participants (66.56%) from across Tehran would like to accept a COVID-19 vaccine; however, this level of acceptance may not be adequate based on some of the estimates COVID-19 herd immunity. The herd immunity point for COVID-19 is evaluated to be between 55% and 82% (32). Actual complete vaccination until February 2022 was 65% in Iran. The current estimation is very close to the real condition. However, acceptance was high, with 46.03% and 26.99% having to intend to have the Iranian and foreign vaccine respectively.
1. Dong E., Du H., Gardner L., 2020. An interactive web-based dashboard to track COVID-19 in real time. The Lancet infectious diseases. 20(5), 533-534.
2. Lim W.S., Liang C.K., Assantachai P., Auyeung T.W., Kang L., Lee W.J., Lim J.Y., Sugimoto K., Akishita M., Chia S.L., 2020. COVID‐19 and older people in Asia: Asian Working Group for Sarcopenia calls to action. Geriatrics & gerontology international. 20(6), 547-558.
3. Le T.T., Cramer J.P., Chen R., Mayhew S., 2020. Evolution of the COVID-19 vaccine development landscape. Nat Rev Drug Discov. 19(10), 667-668.
4. Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., Marc G.P., Moreira E.D., Zerbini C., 2020. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. New England Journal of Medicine. 383(27), 2603-2615.
5. Voysey M., Clemens S.A.C., Madhi S.A., Weckx L.Y., Folegatti P.M., Aley P.K., Angus B., Baillie V.L., Barnabas S.L., Bhorat Q.E., 2021. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. The Lancet. 397(10269), 99-111.
6. Baden L.R., El Sahly H.M., Essink B., Kotloff K., Frey S., Novak R., Diemert D., Spector S.A., Rouphael N., Creech C.B., 2021. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. New England Journal of Medicine. 384(5), 403-416.
7. Sadoff J., Gray G., Vandebosch A., Cárdenas V., Shukarev G., Grinsztejn B., Goepfert P.A., Truyers C., Fennema H., Spiessens B., 2021. Safety and efficacy of single-dose Ad26. COV2. S vaccine against Covid-19. New England Journal of Medicine. 384(23), 2187-2201.
8. Abdool Karim S.S., de Oliveira T., 2021. New SARS-CoV-2 variants—clinical, public health, and vaccine implications. New England Journal of Medicine. 384(19), 1866-1868.
9. Del Rio C., Malani P., 2021. COVID-19 in 2021—Continuing Uncertainty. JAMA. 325(14), 1389-1390.
10. Fine P., Eames K., Heymann D.L., 2011. “Herd immunity”: A rough guide. Clinical infectious diseases. 52(7), 911-916.
11. Neumann-Böhme S., Varghese N.E., Sabat I., Barros P.P., Brouwer W., van Exel J., Schreyögg J., Stargardt T., 2020. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. The European Journal of Health Economics. 21, 977-982.
12. Chew N.W., Cheong C., Kong G., Phua K., Ngiam J.N., Tan B.Y., Wang B., Hao F., Tan W., Han X., 2021. An Asia-Pacific study on healthcare workers’ perceptions of, and willingness to receive, the COVID-19 vaccination. International Journal of Infectious Diseases. 106, 52-60.
13. Smith N., Graham T., 2019. Mapping the anti-vaccination movement on Facebook. Information, Communication & Society. 22(9), 1310-1327.
14. Scheres J., Kuszewski K., 2019. The Ten Threats to Global Health in 2018 and 2019. A welcome and informative communication of WHO to everybody. Zeszyty Naukowe Ochrony Zdrowia. Zdrowie Publiczne i Zarzadzanie. 17(1), 2-8.
15. Caron-Poulin L., Rotondo J., Cutler J., Desai S., Squires S., 2017. Burden and deaths associated with vaccine preventable diseases in Canada, 2010-2014. Online Journal of Public Health Informatics. 9(1). doi: 10.5210/ojphi.v9i1.7676
16. Murphy J., Vallières F., Bentall R.P., Shevlin M., McBride O., Hartman T.K., McKay R., Bennett K., Mason L., Gibson-Miller J., 2021. Psychological characteristics associated with COVID-19 vaccine hesitancy and resistance in Ireland and the United Kingdom. Nature Communications. 12(1), 1-15.
17. Skoda E.M., Teufel M., Stang A., Jöckel K.H., Junne F., Weismüller B., Hetkamp M., Musche V., Kohler H., Dörrie N., 2020. Psychological burden of healthcare professionals in Germany during the acute phase of the COVID-19 pandemic: Differences and similarities in the international context. Journal of Public Health. 42(4), 688-695.
18. Organization W.H., 2017.Vaccination and trust: how concerns arise and the role of communication in mitigating crises. In Vaccination and trust: how concerns arise and the role of communication in mitigating crises.
19. Blanchard J.l., Johnson C., McIntyre M., Crowcroft N.S., McLellan A., 2020. A pre and post intervention study measuring the effect of interactive education on adolescent perceptions of vaccines, vaccine safety and disease risk. Journal of Public Health. 42(3), e272-e277.
20. Salali G.D., Uysal M.S., 2020. COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychological Medicine. 52(15), 3750-3752.
21. Ali S.H., Foreman J., Tozan Y., Capasso A., Jones A.M., 2020. DiClemente, R. J., Trends and predictors of COVID-19 information sources and their relationship with knowledge and beliefs related to the pandemic: nationwide cross-sectional study. JMIR Public Health and Surveillance. 6(4), e21071.
22. Chou W.Y.S., Budenz A., 2020. Considering emotion in COVID-19 vaccine communication: addressing vaccine hesitancy and fostering vaccine confidence. Health Communication. 35(14), 1718-1722.
23. Mariani R., Renzi A., Di Trani M., Trabucchi G., Danskin K., Tambelli R., 2020. The impact of coping strategies and perceived family support on depressive and anxious symptomatology during the coronavirus pandemic (COVID-19) lockdown. Frontiers in Psychiatry. 11, 1195.
24. Ferrucci R., Averna A., Marino D., Reitano M.R., Ruggiero F., Mameli F., Dini M., Poletti B., Barbieri S., Priori A., 2020. Psychological impact during the first outbreak of COVID-19 in Italy. Frontiers in Psychiatry. 11, 559266.
25. Larson H.J., Jarrett C., Eckersberger E., Smith D.M., Paterson P., 2014. Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012. Vaccine. 32(19), 2150-2159.
26. Moccia G., Carpinelli L., Savarese G., Borrelli A., Boccia G., Motta O., Capunzo M., De Caro F., 2021. Perception of Health, Mistrust, Anxiety, and Indecision in a Group of Italians Vaccinated against COVID-19. Vaccines. 9(6), 612.
27. Fadda M., Albanese E., Suggs L.S., 2020. When a COVID-19 vaccine is ready, will we all be ready for it? International Journal of Public Health. 65, 711-712.
28. Spitzer R., Kroenke K., Williams J., 2006. Generalized anxiety disorder 7-item (GAD-7) scale. Arch Intern Med. 166, 1092-7.
29. Kroenke K., Spitzer R.L., Williams J.B., 2001. The PHQ‐9: validity of a brief depression severity measure. Journal of General Internal Medicine. 16(9), 606-613.
30. Besharat M., 2009. Reliability and Validity of a short form of the Mental Health Inventory in an Iranian population. Scientific Journal of Forensic Medicine. 15(2), 87-91.
31. Veit C.T., Ware J.E., 1983. The structure of psychological distress and well-being in general populations. Journal of Consulting and Clinical Psychology. 51(5), 730.
32. Sanche S.L.Y., Xu C, 2020. Romero-Severson E, Hengartner N, Ke R. , High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2. Emerg Infect Dis. 26(7), 1470–1477.
33. Li J., Aipire A., Zhao H., Yuan P., Li J., 2019. Pleurotus ferulae polysaccharides improve the antitumor efficacy of therapeutic human papillomavirus dendritic cell-based vaccine. Human Vaccines & Immunotherapeutics. 15(3), 611-619.
34. Bendau A., Plag J., Petzold M.B., Ströhle A., 2021. COVID-19 vaccine hesitancy and related fears and anxiety. International Immunopharmacology. 97, 107724.
35. Malik A., McFadden S., Elharake J., Omer S., 2020. Determinants of COVID-19 vaccine acceptance in the US. EClinicalMedicine. 2020, 26.
36. Reiter P.L., Pennell M.L., Katz, M.L., 2020. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. 38(42), 6500-6507.
37. Kaadan M.I., Abdulkarim J., Chaar M., Zayegh O., Keblawi M.A., 2021. Determinants of COVID-19 vaccine acceptance in the Arab world: a cross-sectional study. Global Health Research and Policy. 6(1), 1-7.
38. Runciman C., Roberts B., Alexander K., Bohler-Muller N., Bekker M., 2021. UJ-HSRC COVID-19 democracy survey: Willingness to take a Covid-19 vaccine: A research briefing. University of Johannesburg. Retrieved November. 10, 2021.
39. Bono S.A., Faria de Moura Villela E., Siau C.S., Chen W.S., Pengpid S., Hasan M.T., Sessou P., Ditekemena J.D., Amodan B.O., Hosseinipour M.C., 2021. Factors affecting COVID-19 vaccine acceptance: An international survey among Low-and Middle-Income Countries. Vaccines. 9(5), 515.
40. Lazarus J.V., Ratzan S., Palayew A., Gostin L.O., Larson H.J., Rabin K., Kimball S., El-Mohandes A., 2020. Hesitant or not? A global survey of potential acceptance of a COVID-19 vaccine. Nature Medicine. 27(2), 225-228.
41. Sallam M., Dababseh D., Eid H., Al-Mahzoum K., Al-Haidar A., Taim D., Yaseen A., Ababneh N.A., Bakri F.G., Mahafzah A., 2021. High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: A study in Jordan and Kuwait among other Arab countries. Vaccines. 9(1), 42.
42. McNally R., Mair P., Mugno B., Riemann B., 2017. Co-morbid obsessive–compulsive disorder and depression: A Bayesian network approach. Psychological Medicine. 47(7), 1204-1214.
43. Lee T.T., 2010. Why they don’t trust the media: An examination of factors predicting trust. American behavioral scientist. 54(1), 8-21.
44. Tomljenovic H., Bubic A., Erceg N., 2021. Contribution of rationality to vaccine attitudes: Testing two hypotheses. Journal of Behavioral Decision Making. 35(2), e2260.
45. Fridman I., Lucas N., Henke D., Zigler C.K., 2020. Association between public knowledge about COVID-19, trust in information sources, and adherence to social distancing: cross-sectional survey. JMIR public health and surveillance. 6(3), e22060.
46. Painter M., Qiu T., 2020. Political beliefs affect compliance with covid-19 social distancing orders. Covid Economics. 4, 103-123.
47. Karić T., Međedović J., 2021. COVID-19 Conspiracy beliefs and containment-related behaviour: the role of political trust. Personality and Individual Differences. 175, 110697.
48. Head K.J., Kasting M.L., Sturm L.A., Hartsock J.A., Zimet G.D.A., 2020. National survey assessing SARS-CoV-2 vaccination intentions: Implications for future public health communication efforts. Science Communication. 42(5), 698-723.
49. Sun R., Wang X., Lin L., Zhang N., Li L., Zhou X., 2021. The impact of negative emotional reactions on parental vaccine hesitancy after the 2018 vaccine event in China: A cross-sectional survey. Human Vaccines & Immunotherapeutics. 17(9), 3042-3051.
50. Eyllon M., Dang A.P., Barnes J.B., Buresh J., Peloquin G.D., Hogan A.C., Nordberg S.S., 2022. Associations between psychiatric morbidity and COVID-19 vaccine hesitancy: An analysis of electronic health records and patient survey. Psychiatry Research. 307, 114329.
51. Madison A.A., Shrout M.R., Renna M.E., Kiecolt-Glaser J.K., 2021. Psychological and behavioral predictors of vaccine efficacy: Considerations for COVID-19. Perspectives on Psychological Science. 16(2), 191-203.
52. Kwok K.O., Li K.K., Wei W.I., Tang A., Wong S.Y.S., Lee S.S., 2021. Influenza vaccine uptake, COVID-19 vaccination intention and vaccine hesitancy among nurses: A survey. International Journal of Nursing Studies. 114, 103854.
53. Conway L., Woodard S.R., Zubrod A., Chan L., 2020. Why are conservatives less concerned about the coronavirus (COVID-19) than liberals? Testing experiential versus political explanations. PsyArXiv Preprints. DOI:10.31234/osf.io/fgb84
54. Tal O., Ne’eman Y., Sadia R., Shmuel R., Schejter E., Bitan M., 2021. Parents’ attitudes toward children’s vaccination as a marker of trust in health systems. Human Vaccines & Immunotherapeutics. 17(11), 4518-4528.
55. Hornsey M.J., Finlayson M., Chatwood G., Begeny C.T., 2020. Donald Trump and vaccination: The effect of political identity, conspiracist ideation and presidential tweets on vaccine hesitancy. Journal of Experimental Social Psychology. 88, 103947.
56. Zarocostas J., 2004. UNICEF taps religious leaders in vaccination push. The Lancet. 363(9422), 1709.
57. Vergara R.J.D., Sarmiento P.J.D., Lagman J.D.N., 2021. Building public trust: a response to COVID-19 vaccine hesitancy predicament. Journal of Public Health. 43(2), e291-e292.
58. Iyengar S., Lelkes Y., Levendusky M., Malhotra N., Westwood S.J., 2019. The origins and consequences of affective polarization in the United States. Annual Review of Political Science. 22, 129-146.
59. Druckman J.N., Klar S., Krupnikov Y., Levendusky M., Ryan J.B., 2020. How affective polarization shapes Americans’ political beliefs: A study of response to the COVID-19 pandemic. Journal of Experimental Political Science. 8(3), 223-234.
